US · Healthcare

Whitehawk Therapeutics, Inc. (WHWK)

Biotechnology

Whitehawk Therapeutics, Inc. (WHWK) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for WHWK

P/E ratio

25.00

Whitehawk Therapeutics, Inc. (WHWK) — FAQ

What is WHWK's P/E ratio?

The price-to-earnings (P/E) ratio for Whitehawk Therapeutics, Inc. (WHWK) is 25.00 (data as of 2026-05-23).

Does Whitehawk Therapeutics, Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Whitehawk Therapeutics, Inc. (WHWK). Check the MyAverix Finance app for the latest dividend data.

What sector is Whitehawk Therapeutics, Inc. in?

Whitehawk Therapeutics, Inc. (WHWK) is classified in the Healthcare sector (Biotechnology industry).

What exchange is WHWK listed on?

WHWK is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)